Direct Oral Anticoagulants Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)

Skip to Content

Clinical Trial Details

Direct Oral Anticoagulants Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)

Direct Oral Anticoagulants Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)

Objective

Visit the National Cancer Institute's Web Site.

A study to determine the effectiveness of LMWH/ warfarin vs. DOAC anticoagulation for preventing recurrent VTE in cancer patients.

IRB Protocol Number
AFT-28 “CANVAS” NCT#02744092

Clinical Trial Categories

  • Other
Contact
NH Oncology Hematology Clinical Research Dept. at 603-224-2556

Location

  • Concord Hospital
    250 Pleasant Street
    Concord, NH 03110
    Main: 603-225-2711
    Alternate: 800-327-0464